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RESEARCH ARTICLE
Modelling severe Staphylococcus aureus 
sepsis in conscious pigs: are implications 
for animal welfare justified?
Helle G. Olsen1*, Mads Kjelgaard‑Hansen2,6, Pernille Tveden‑Nyborg1, Malene M. Birck1, Karsten P. Hammelev3, 
Andreas Vegge4,6, Bent Aalbæk1, Páll S. Leifsson1, Henrik E. Jensen1, Tine Iburg1,5, Peter M. H. Heegaard5 
and Ole L. Nielsen1
Abstract 
Background: A porcine model of haematogenous Staphylococcus aureus sepsis has previously been established 
in our research group. In these studies, pigs developed severe sepsis including liver dysfunction during a 48 h study 
period. As pigs were awake during the study, animal welfare was challenged by the severity of induced disease, which 
in some cases necessitated humane euthanasia. A pilot study was therefore performed in order to establish the suf‑
ficient inoculum concentration and application protocol needed to produce signs of liver dysfunction within limits of 
our pre‑defined humane endpoints.
Methods: Four pigs received 1 × 108 cfu/kg BW of S. aureus, and two controls were sham inoculated with saline. 
A fixed infusion rate of 3 mL/min was used, while the inoculum concentration, i.e., the dose volume, was changed 
between the pigs. The following dose volumes were used: 10 mL (n = 1), 20 mL (n = 2), and 30 mL (n = 1), corre‑
sponding to infusion durations of 3.33, 6.66, and 10 min at dose rates of 3 × 107, 1.5 × 107, and 1 × 107 cfu/min/kg 
BW, respectively. Blood samples were drawn for complete blood count, clinical chemistry, and inflammatory markers 
before and every 6 h after inoculation. Prior to euthanasia, a galactose elimination capacity test was performed to 
assess liver function. Pigs were euthanised 48 h post inoculation for necropsy and histopathological evaluation.
Results: While infusion times of 6.66 min, and higher, did not induce liver dysfunction (n = 3), the infusion time of 
3.33 min (n = 1) caused alterations in parameters similar to what had been seen in our previous studies, i.e., increasing 
bilirubin and aspartate aminotransferase, as well as histopathological occurrence of intravascular fibrin split products 
in the liver. This pig was however euthanised after 30 h, according to humane endpoints.
Conclusions: A usable balance between scientific purpose and animal welfare could not be achieved, and we there‑
fore find it hard to justify further use of this conscious porcine sepsis model. In order to make a model of translational 
relevance for human sepsis, we suggest that future model versions should use long‑term anaesthesia.
Keywords: Sepsis, Pigs, Animal model, Galactose elimination capacity (GEC), Liver dysfunction, Humane endpoints, 
Animal welfare
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publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Background
The liver plays a central role in sepsis, being a multi-
functional organ. Within human intensive care units 
(ICUs), cholestatic liver dysfunction is a frequent inci-
dence which may arise from multiple factors such as 
infection, sepsis, major surgery, blood transfusions, par-
enteral nutrition, and use of antibiotics and other drugs 
with hepatotoxic side effects [1–3]. The diagnosis is 
commonly based on increased serum concentrations of 
bilirubin, supported by increases in liver enzymes such 
as the transaminases aspartate aminotransferase (AST) 
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and alanine aminotransferase (ALT), alkaline phos-
phatase (AP), lactate dehydrogenase, and/or occurrence 
of hypoalbuminemia [4]. Persistent hyperbilirubinemia is 
associated with increased mortality [5, 6], also in patients 
with Staphylococcus aureus sepsis [7]. The pathogenesis 
of sepsis-related liver dysfunction is however not well 
understood [2, 3].
The aims of the study reported in this paper were 
twofold: (1) We have previously performed two related 
sepsis model experiments in pigs inoculated hematog-
enously with S. aureus [8, 9], with a study duration of 
up to 48 h. The pigs were at a conscious state (i.e., un-
anaesthetised) during the observation period from inoc-
ulation to euthanasia. Clinical signs of sepsis included 
increased body temperature, neutrophilia, increased 
C-reactive protein (CRP) and interleukin-6 (IL-6), and 
decreased serum iron. Increasing hypercoagulability 
and decreasing numbers of platelets indicated dysfunc-
tion of the blood clotting system, and of special note, 
liver dysfunction was indirectly indicated by hyperbili-
rubinemia, increased AST together with normal levels 
of creatine kinase (CK), as well as fibrin exudation from 
small vessels within the liver. There were few to none 
bacteria cultured from liver tissue, suggesting that the 
hepatic affection was part of a systemic inflammatory 
response rather than due to local hepatic infection [8, 
9]. These observations led to the hypothesis that pigs 
with experimental S. aureus sepsis develop liver dys-
function. The first objective of this study was therefore 
to establish a method with which we could confirm and 
quantify presence of liver dysfunction in pigs 48 h after 
hematogeneous inoculation with S. aureus, i.e., by intro-
ducing the galactose elimination capacity test (GEC) to 
the experimental setup. (2) Animal welfare and model 
robustness however remained a challenge in the study 
design: some pigs responded with apnoea and cardiac 
arrest during the inoculation procedure, and other pigs 
were euthanised before scheduled due to development 
of severe clinical disease, i.e., respiratory impairment 
from acute, severe pneumonia [8, 9]. The inoculum con-
centration has previously been suggested to play a role 
in directing the severity of sepsis in this model [10]. We 
used this observation to form our second hypothesis 
for this study, namely that the rate [cfu/min/kg body 
weight (BW)] of infusion of S. aureus is determining 
for the degree of induced clinical disease. In order to 
accomplish the first objective regarding quantification 
of liver dysfunction, the second objective of the study 
was therefore to establish the inoculum concentration 
and application protocol needed to produce signs of 
liver dysfunction without causing adverse effects during 
inoculation and without reaching pre-defined humane 
endpoints during the 48 h study period.
In brief, this article reports that re-construction of 
signs of liver dysfunction could not be achieved within 
the limits of our pre-defined humane endpoints, and a 
usable balance between scientific objectives and animal 
welfare therefore seems difficult to establish for this con-
scious porcine sepsis model.
Methods
Animals
The study was carried out in accordance with a protocol 
approved by the Danish Animal Experiments Inspector-
ate (license no. 2012-15-2934-00702), in compliance with 
Directive 2010/63/EU of the European Parliament and of 
the council of 22 September 2010 on the protection of 
animals used for scientific purposes [11].
Six female, juvenile, crossbred pigs (Danish Landrace/
Yorkshire/Duroc) from a specific pathogen free pig herd 
were used. The sample size was determined based on 
convenience sampling. At arrival, S. aureus was recov-
ered from the nasal cavity or perineum from three out 
of six pigs (Case-3, Case-4, and Control-2), indicat-
ing environmental exposure prior to commencement of 
this experiment (method provided under the heading 
“Pathology and bacteriology“).
The pigs were regarded as clinically healthy based on 
evaluation of standard haematology and biochemistry 
results from blood samples obtained at arrival, as well 
as on daily visual inspections during the acclimatisation 
period of 8–19  days. The pigs were fed a commercial 
swine feed and housed in groups during the acclimatisa-
tion period. Body weight (BW) was 30‒36 kg at the day of 
inoculation.
Establishment of permanent IV access
One to 3 days before inoculation, pigs were premedicated 
intramuscularly with a combination of the following 
drugs: 0.83  mg/kg BW zolazepam and 0.83  mg/kg BW 
tiletamine (Zoletil 50/50® vet; Virbac, Carros, France), 
0.83 mg/kg BW xylazine (Narcoxyl® 20 mg/mL; Intervet, 
Boxmeer, Netherlands), 0.83 mg/kg BW ketamine (Keta-
minol® 100  mg/mL; Intervet, Boxmeer, Netherlands), 
and 0.17  mg/kg BW butorphanol (Torbugesic® 10  mg/
mL; ScanVet, Fredensborg, Denmark). This premedica-
tion combination was recommended by the local labo-
ratory animal facility staff who use it routinely for pigs. 
The pigs were shifted to IV propofol infusion (6  mg/kg 
BW/h; Rapinovet® vet 10 mg/mL; Schering-Plough Ani-
mal Health, Ballerup, Denmark) as soon as IV access was 
gained (see below).
A permanent central vein catheter (BD Careflow 3 or 4 
Fr, 20 cm, Cat.nos. 681643 or 681649; BD, NJ, USA) was 
aseptically inserted through the auricular vein of each 
ear, and guided into the jugular vein. The catheter was 
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fixed to the ear pinna with sutures (poly-filament, non-
absorbable Dagrofil suture 0; B.Braun, Tuttlingen, Ger-
many) and adhesive bandages. To prevent clotting of the 
catheters, 2.5–3.5  mL saline with heparin (1000  IE/mL) 
(Heparin Leo® 5000 IE; Leo Pharma, Ballerup, Denmark) 
was deposited as lock solution. The pigs were allowed to 
recover from anaesthesia and subsequently housed indi-
vidually in biosecurity level 2 stables for the remainder of 
the study period.
Inoculation and experimental design
During the inoculation procedure 1–3  days after estab-
lishment of IV access, pigs were anaesthetised for the sec-
ond time using the same premedication and anaesthetic 
protocol as described for the IV access procedure above. 
The pigs were intubated and spontaneously breathing 
atmospheric air supplied with oxygen from a hose placed 
near the tube opening (100 % oxygen, 0.5–1.0 L/min) and 
monitored with echocardiography and pulse oximetry.
The experiment was carried out in three consecutive 
rounds, with one inoculated pig and one control pig in 
each of the first two rounds and two inoculated pigs in 
the third round (Fig. 1). The allocation was based on con-
venience sampling.
A swine-specific strain of S. aureus (isolate S54F9) 
[12, 13] was infused through the left auricular IV 
catheter in four pigs at a dose of 1 ×  108  cfu/kg BW 
suspended in 0.9  % NaCl. The infusion time cor-
responded to dose volumes of 30, 10, and 20  mL 
in rounds one, two and three, respectively, using 
a fixed infusion rate of 3  mL/min (Alaris CC Plus 
Syringe Pump). Infusion durations were thus 10, 
3.33, and 6.66  min, respectively, which corresponded 
to inoculum dose rates of 1  ×  107, 3  ×  107, and 
1.5  ×  107  cfu/min/kg BW. Inoculum concentrations 
were 3.33 × 106, 1 × 107, and 5 × 106 cfu/mL/kg BW. 
Two control pigs were infused with volumes of saline 
(0.9  % NaCl) corresponding to their parallel inocu-
lated cases (Fig. 1). S. aureus inoculum was prepared 
as previously described [14].
Observation period following inoculation
After completion of inoculation, pigs were allowed to 
recover from anaesthesia, while a self-retracting swivel 
line was attached to a harness on the pig (Trixie dog har-
ness, size L, Tarp, Germany) [15], allowing the pig to 
move around freely. Via this line, a connector tube was 
led from the right ear vein catheter and outside the pen, 
enabling permanent vascular access for repeated blood 
sampling and infusion of IV analgesics without requiring 
to restrain the pig. A constant infusion of isotonic saline 
(0.9 % NaCl; 3 mL/h) was set to keep the vein open, and 
only interrupted during blood sampling or infusion of 
analgesics.
The pigs were observed frequently during the 
experimental study period (0–6  h intervals). Clinical 
examinations (e.g. body temperature measurements, aus-
cultations, oxygen saturation measurements) were only 
made on indication, i.e., when a pig’s clinical condition 
was judged as deteriorating or distressing. Buprenorphin, 
0.01‒0.02  mg/kg BW (Temgesic® 0.3  mg/mL, Reckitt 
Benckiser, United Kingdom) was administered IV to all 
inoculated pigs and control pigs every 6 h throughout the 
experimental study period.
Fig. 1 Study overview. The study was conducted in three consecutive rounds over 15 days. B indicates baseline blood samples which were 
obtained at the IV catheterisation procedure (cath.), i.e., 1–3 days before inoculation. GEC galactose elimination capacity test
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Humane endpoints
Humane endpoints were based on the ones used in pre-
vious sepsis studies conducted by our group [8, 9], and 
were elaborated further to reduce subjectivity in the 
assessment of animal welfare. In short, the endpoints 
included: (1) Signs of severe dyspnoea, defined as an 
inability of the pig to keep oxygen saturation above 90 %. 
(2) Inability to get up and/or move. (3) Signs indicating 
encephalitis, e.g. nystagmus, paresis, or head tilt.
Blood measurements
Baseline blood samples (B) were drawn from the IV cath-
eter 1–3  days before inoculation (Fig.  1). Starting just 
prior to inoculation (0 h PI), blood was further sampled 
every 6 h throughout the remaining study period.
Haematology was performed using EDTA stabilized 
whole blood (ADVIA 120 analyzer, Bayer Healthcare 
Diagnostics). Clinical chemistry analyses were performed 
on serum (ADVIA 1650, Bayer Healthcare Diagnostics). 
C-reactive protein was analysed using a dendrimer-cou-
pled cytidine diphosphocholine sandwich enzyme-linked 
immunosorbent assay (ELISA) [16]. Serum amyloid A 
(SAA) was measured with a sandwich ELISA (Phase SAA 
assay, Tridelta Development Ltd.) as originally described 
by McDonald et al. [17]. IL-6 was measured using sand-
wich ELISAs from R and D Systems (Quantikine PTA00 
and Duoset DY686, respectively). All samples were tested 
in duplicate, with detection limits of 70.8 ng/mL (CRP), 
31.25 µg/mL (SAA), and 62.5 pg/mL (IL-6). Blood sam-
ples for bacterial culture (5 mL) were obtained at 0 h PI 
(before inoculation) and at the following time points PI: 
6, 12, 24, 36, and 48 h.
Galactose elimination capacity test
After 43‒44 h post inoculation (PI), the pigs were trans-
ferred to a surgical facility for initiation of GEC test (see 
below). They were anaesthetised for the third time using 
the same premedication and anaesthetic protocol as 
described for the catheterisation procedure above, except 
that propofol dosing was adjusted to a range of 5‒10 mg/
kg BW/h and supplemented with IV fentanyl (10‒30 µg/
kg BW/h, Haldid® 50  μg/mL; Janssen-Cilag A/S, Birk-
erød, Denmark). Upon anaesthesia, pigs were intubated 
and mechanically ventilated. An incision was made in the 
ventral neck followed by insertion of a catheter (Avanti 
catheter, 6-Fr., cat.no. 504-606X, Cordis, Fremont, CA, 
USA) into the carotid artery for arterial blood sampling. 
A urinary catheter (Foley 8 Ch, Rüsch, Kernen, Germany) 
was placed for collection of urine.
The GEC was performed as described by Tygstrup [18] 
with minor adaptations: Galactose (0.5  g/kg BW, 12  % 
solution; cat. no. G0750-500G, Sigma-Aldrich, St. Louis, 
MO, USA) was infused IV over 5 min through the right 
ear IV catheter. Heparin-stabilised arterial blood samples 
were obtained at five-min intervals in the period between 
15–60  min after start of infusion. Blood samples were 
centrifuged within 30 min of sampling (4 °C in 10 min at 
2500 rpm), and plasma was kept at −20 °C until analysis. 
Urine was collected for 4 h after start of galactose infu-
sion. The total volume of urine was noted, and a sample 
was obtained and kept at −20 °C until analysis. Galactose 
plasma concentration was measured enzymatically (Pen-
tra-400, Horiba medical) by the galactose dehydroge-
nase (cat. no. 10104981001, Roche, Hvidovre, Denmark) 
method after deproteinisation with 0.33  M perchloric 
acid [19]. All samples were run in duplicates. The GEC 
rate was calculated as described by Tygstrup [18] and 
Jepsen et  al. [20], using the formula: GEC  =  (A–U)/
(tcj=0 + 7) mmol/min, where A is the amount of galactose 
injected, U is the amount of galactose excreted in urine 
collected over 4  h, tcj=0 is the intercept with the time 
axis of a straight line fitted to the linear part of the time/
arterial blood galactose concentration curve (i.e., the 
saturated period). The constant ‘7’ is a correction for the 
time-delay of galactose equilibration between extra- and 
intravascular spaces.
Euthanasia
After completion of the GEC test, the pigs were euthan-
ised by axillary exsanguination immediately following 
administration of a propofol overdose (3–6 mg/kg BW).
Pathology and bacteriology
A full necropsy was performed, and tissue samples for 
histopathology were obtained in duplicates from hepatic 
lymph nodes and five pre-defined areas of the liver. 
Samples were fixed in 10 % formalin for 24 h, processed 
routinely, and cut in sections of 3–4  µm. Sections were 
stained with haematoxylin and eosin and blinded prior to 
evaluation. Presence of hyaline globules in liver sections 
was evaluated by haematoxylin-eosin (HE), phospho-
tungstic acid haematoxylin (PTAH), martius scarlet blue 
(MSB), and fibrinogen immunohistochemistry stains, as 
described previously [21].
Bacteriological examinations of S. aureus in tis-
sue samples were performed as previously described 
[14]. Samples for bacteriology were obtained from liver, 
lung, spleen, bone marrow, peritoneal fluid, as well as 
from cases of suppurative auricular vein infection. Cot-
ton swab samples obtained from nostrils and perineum 
prior to the experiment in order to check S. aureus colo-
nisation status were transferred to enrichment medium 
consisting of 10  mL Brain Heat Infusion Broth (Oxoid 
CM1135) supplied with 7.5  % NaCl. After incubation 
at 37  °C/24  h the enrichment culture was streaked on 
blood agar medium (Blood agar base, Oxoid CM0055, 
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supplied with 5 % sterile bovine blood). Haemolytic colo-
nies were isolated and identified by Matrix-assisted laser 
desorption ionixation-time of flight mass spectrometry 
(MALDI-TOF MS) on a Vitec MS (Biomérieux) using 
Saramis software (Biomérieux).
Results
Inoculated pigs
Case‑1 (1 × 107 cfu/min/kg BW; 10 min infusion)
Only mild tachycardia during bacterial infusion (heart 
rate increase from 60 to 90 beats per min) was observed. 
The pig was agitated and restless during the first 6  h; 
thereafter it became recumbent and was reluctant to 
stand up. It became anorectic, but remained willing 
to drink water. Respiration was superficial and lightly 
elevated. Extremities became cold. This pig completed 
the study period without reaching any of the humane 
endpoints. Sepsis was indicated by increased body tem-
perature (onset at 30 h PI), bacteraemia, and neutrophilia, 
together with increased IL-6, CRP, SAA, and decreased 
iron (Fig.  2). There were no remarkable alterations in 
liver blood parameters, except an increase in total bili-
rubin blood concentration between 24–42  h PI (Fig.  3). 
Pathological and bacteriological findings are summarised 
in Table 1. The GEC rate at 44 h PI was 1.43 mmol/min 
(Fig. 4).
Case‑2 (3 × 107 cfu/min/kg BW; 3.33 min infusion)
Besides mild tachycardia, a brief, self-limited epi-
sode of cardiac arrhythmia occurred during bacterial 
Fig. 2 Markers of systemic inflammation. Within the group of inoculated pigs, one pig (Case‑2) distinguished itself from the others by having gen‑
erally an earlier onset of response, and also a more pronounced response. Blood samples were not obtained from Control‑1 between 24–48 h due 
to a defect catheter. B baseline sample
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infusion. This pig showed earlier and more severe clini-
cal signs than the other pigs, i.e., it became apathetic 
and had muscle tremors. At 30  h PI, this pig was no 
longer able to stand up, and was euthanised accord-
ing to the humane endpoint: “inability to get up and/
or move.” Sepsis was indicated by increased body tem-
perature (onset at 18  h PI), bacteraemia, and neutro-
philia, together with increased IL-6, CRP, SAA, and 
decreased serum iron. Compared to the other pigs in 
the study, these alterations occurred earlier and/or were 
more pronounced (Fig. 2). Bilirubin was increased from 
12 h PI and onwards (Fig. 3a). Furthermore, AST levels 
peaked at 6 h PI (fivefold, compared to baseline value) 
(Fig.  3b) and remained elevated. A similar pattern was 
found for CK levels (Fig. 3c), indicating that at least part 
of the rise in AST was due to myocyte injury rather than 
hepatocyte injury. Yet, when compared to the other pigs 
in the study, AST levels were markedly increased, while 
CK levels were similar to the levels of the other pigs. The 
extent and degree of pathological and bacteriological 
findings was similar to the other inoculated pigs, except 
that no lung lesions were noted. Histologically, aggre-
gations of fibrin split products (hyaline globules) were 
found in small vessels throughout the liver (Table 1) as 
also seen in a subset of septic pigs in one of our pre-
vious studies [21], however fibrin exudation from small 
hepatic vessels was not evident. GEC was not measured 
in this pig due to its pre-scheduled euthanasia.
Case‑3 and Case‑4 (1.5 × 107 cfu/min/kg BW; 6.66 min 
infusion)
Clinically, both pigs behaved in similar fashion as Case-
1. Both ingested small amounts of feed during the 
study period, and no humane endpoints were reached. 
As for the other inoculated pigs, sepsis was indicated 
by increased body temperature (onset at 15 and 22  h, 
respectively), bacteraemia, and neutrophilia, together 
with increased IL-6, CRP, SAA, and decreased serum iron 
(Fig. 2). Except from a transient increase in total bilirubin 
between 24‒42 h in Case-3, liver parameters were unaf-
fected (Fig.  3). Pathological and bacteriological findings 
resembled those of the other inoculated pigs (Table  1). 
Case-4 had suppurative auricular phlebitis. GEC rates at 
44 h PI were 1.47  mmol/min (Case-3) and 1.79  mmol/
min (Case-4) (Fig. 4).
Control pigs
Although clinically unaffected, S. aureus suppurative 
auricular phlebitis was found in both control pigs at nec-
ropsy (Table  1). Control-2 had extensive phlegmon in 
relation to the phlebitis and displayed positive S. aureus 
blood culture at a single time point as well as dissemi-
nated hepatic microabscesses, while curiously, no bac-
teria were cultured from the liver tissue. Furthermore, 
altered blood inflammatory parameters were found in 
this pig: Neutrophilia, increased CRP, SAA, and IL-6, and 
decreased iron (Fig. 2). The infection most likely resided 
from the catheterisation procedure, as many of the 
parameters had started to increase prior to inoculation. 
None of this was seen in Control-1, however its interpre-
tation is impeded by the lack of blood samples in the time 
between 24–48 h due to a defect catheter. GEC rates at 
44 h PI were 1.39 mmol/min (Control-1) and 1.41 mmol/
min (Control-2) (Fig. 4).
Discussion
In this study, an optimal balance between our research 
objectives and animal welfare criteria were sought, but 
not achieved.
Fig. 3 Blood parameters for assessment of hepatic function. B 
baseline sample
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Dynamic liver function measurement
Observations from our previous experimental porcine 
sepsis studies led to the hypothesis of liver dysfunc-
tion. Especially notable was the increase in total serum 
bilirubin (range of induced increase: 2–12 µmol/L [8, 9]). 
Bilirubin is however not a specific marker of liver dys-
function, as increases may also occur due to intravascular 
haemolysis. S. aureus possess a number of virulence fac-
tors, and of special interest in this regard is their ability 
to produce a number of haemolytic exotoxins in order 
to obtain iron from host erythrocytes. Considering the 
experimental setup of introducing large amounts of S. 
aureus to the blood stream, it is not unlikely that Staphy-
lococcal haemolytic exotoxins [22] could have caused the 
observed increase in bilirubin levels, hereby indicating 
intravascular haemolysis rather than liver dysfunction. 
The observed fibrin leakage from hepatic vessels, on the 
other hand, seemed in support for the hypothesis of liver 
dysfunction, yet this could also be the result of a primary 
vascular dysfunction. In order to confirm our hypoth-
esis of liver dysfunction, a specific, quantitative measure-
ment of hepatic function was needed, and we therefore 
included the GEC test as a direct measure of the liver’s 
metabolic functional capacity.
As both control pigs displayed infections in and around 
the auricular veins, their status as true, healthy controls 
may be argued. Yet, since all indications of liver dysfunc-
tion were absent in both inoculated pigs and control pigs, 
except from Case-2, the obtained GEC rates most likely 
represent normal liver function. To our knowledge, only 
a few studies have reported GEC rates in healthy pigs; of 
these, our findings are within the range of those obtained 
in one study [23], while being a little higher (roughly 
estimated to one-third) than the rates obtained in two 
other studies [24, 25], despite the use of pigs of same 
breed, sex, and age. The reason for this discrepancy is 
currently unknown.
Animal welfare and model robustness
The hypothesis originally formulated by Soerensen 
et al. [10] suggested a link between the inoculation rate 
and clinical response. The mechanism is not known, 
but perhaps rapid bacterial infusion could cause some 
kind of initial intoxication or extreme pulmonary 
hypertension that would have a negative effect on some 
immunological barriers, leading to enforced bacte-
rial invasion and growth. The hypothesis was further 
strengthened by this study, since the pig inoculated by 
the highest inoculation rate (Case-2) experienced the 
most severe outcome and alterations in parameters 
similar to what had been seen in previous studies, i.e., 
increasing bilirubin and AST, as well as the histopatho-
logical occurrence of intravascular hyaline globules 
in the liver, yet without any signs of fibrin exudation. 
Case-2, however, became clinically affected to the 
extent that it had to be euthanised after 30  h, accord-
ing to humane endpoints. The three remaining pigs 
inoculated by lower infusion rates (Case-1, Case-3, and 
Case-4) successfully completed the study period, but 
showed no obvious signs of liver dysfunction. Despite 
the few pigs included, this convincingly illustrates that 
liver dysfunction is less likely to occur without reaching 
any of the pre-defined humane endpoints during a 48 h 
study period. This is a major limitation for the use and 
reproducibility of the model.
This study hereby exemplifies some of the important 
issues and concerns of working with conscious sepsis ani-
mal models. It is inherently an ethical challenge to per-
form sepsis experiments in conscious animals because 
sepsis is a potentially fatal condition, and because the 
later stages of disease are of main interest for transla-
tional research [26].
In this study, we used directly determinable humane 
endpoints based on the knowledge gained from previous 
experimentation, which is crucial, especially when work-
ing with fast-evolving illness. Theoretically, researchers 
could be permitted to change the humane endpoints in 
order to allow further disease progression, if the sought 
knowledge is important enough to compensate for ani-
mal suffering, and as long as it cannot be achieved by 
other means. Another solution is to use long-term anaes-
thesia. While being the most humane solution, long-term 
anaesthesia however has the disadvantage of affecting the 
inflammatory processes and disease progression [27]. On 
the other hand, long-term sedation or anaesthesia is fre-
quently used in the management of patients with severe 
Fig. 4 The time/arterial blood galactose concentration curve during 
GEC testing at 44 h PI. Slopes are identical for all pigs in the saturated, 
linear phase, suggesting identical galactose elimination capacities 
before correction for urinary output. The finding was confirmed by 
calculation of actual GEC rates
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sepsis in ICUs; thus, mimicking such a clinically relevant 
setting may be the most optimal choice for further devel-
opment of this porcine sepsis model.
Conclusions
Re-construction of signs of liver dysfunction could 
not be achieved within the limits of our pre-defined 
humane endpoints. In light of this result, a usable balance 
between scientific purpose and animal welfare appears 
unfeasible, and we find it hard to justify any further use 
of this conscious porcine sepsis model. We suggest that 
this model should be re-established as a long-term anaes-
thesia model in order to make a model of translational 
relevance for human sepsis.
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